Eagle's Eye View: Day 1 Highlights | AHA 2019

In this special episode of the View, Dr. Peter Block and Dr. Deepak Bhatt discuss highlights from Day 1 of AHA.19, including the Dapagliflozin and Prevention of Adverse-Outcomes in HF Trial (DAPA-HF), the Colchicine Cardiovascular Outcomes Trial (COLCOT), and the International Study Of Comparative Health Effectiveness With Medical And Invasive Approaches (ISCHEMIA) trials.

Subscribe on iTunes | Subscribe on Google Play

Clinical Topics: Acute Coronary Syndromes, Anticoagulation Management, Arrhythmias and Clinical EP, Cardiac Surgery, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Prevention, ACS and Cardiac Biomarkers, Anticoagulation Management and ACS, Implantable Devices, SCD/Ventricular Arrhythmias, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Lipid Metabolism, Acute Heart Failure, Heart Failure and Cardiac Biomarkers, Interventions and ACS

Keywords: AHA Annual Scientific Sessions, AHA19, EaglesEyeView, Dyslipidemias, Heart Failure, Acute Coronary Syndrome, Angina, Unstable, Colchicine, Diarrhea, Heart Arrest, Inflammation, Myocardial Infarction, Myocardial Revascularization, Percutaneous Coronary Intervention, Primary Prevention, Stroke, Benzhydryl Compounds, Glomerular Filtration Rate, Glucosides, Heart Failure, Hospitalization, Hypotension, Natriuretic Peptide, Brain, Peptide Fragments, Renal Insufficiency, Sodium-Glucose Transporter 2, Stroke Volume


< Back to Listings

ACC Members, discuss
this on Member Hub.